Exchange: NASDAQ·Updated 07:57 PM EST

IMDX News

News
all
press releases
Insight Molecular Diagnostics (NASDAQ:IMDX) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded shares of Insight Molecular Diagnostics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat
Insight Molecular Diagnostics (NASDAQ:IMDX) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded shares of Insight Molecular Diagnostics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat
More News
Lake Street Capital lowered their target price on Insight Molecular Diagnostics to $9.00 and set a "buy" rating on the stock in a research report on Friday...
MarketBeat
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. acquired 3,428,571 shares of the firm's stock in a transaction that occurred on Tuesday, November 17th. The stock was bought at an average price of $1.75 per share, for a total transaction...
MarketBeat
Insight Molecular Diagnostics Inc. (IMDX) Q3 2026 Earnings Call Transcript...
SeekingAlpha
Insight Molecular Diagnostics Inc. 2026 Q3 - Results - Earnings Call Presentation...
SeekingAlpha
Insight Molecular Diagnostics (IMDX) expects to respond before a January 2027 deadline to the U.S. Food and Drug Administration's request for more information about its GraftAssureDx kidney transplant test, executives said on the company's third-quarter earnings call. President and CEO Josh Riggs s...
MarketBeat
Oncocyte (NASDAQ:IMDX - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.19) earnings per share for the quarter...
MarketBeat
Insight Molecular (NASDAQ:IMDX) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcriptsread more...
Benzinga
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
In trading on Monday, biotechnology shares were relative leaders, up on the day by about 2.1%. Leading the group were shares of Insight Molecular Diagnostics, up about 22.8% and shares of Replimune...
Nasdaq News: Markets

Advertisement|Remove ads.